We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Dexion Alp. | LSE:DASL | London | Ordinary Share | GB00B0ZQ8Q41 | ORD NPV GBP |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 85.25 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMDASL RNS Number : 8143U Dexion Alpha Strategies Limited 30 June 2009 Dexion Alpha Strategies Limited (the "Company") May Net Asset Values Ordinary Shares The net asset values of the Company's Ordinary Shares as of 29 May 2009 are as follows:- +--------------+--------------+-------------+-------------+ | Share Class | NAV | May | YTD | | | |Performance |Performance | +--------------+--------------+-------------+-------------+ | GBP Shares | 96.06 pence | +2.52% | +5.39% | +--------------+--------------+-------------+-------------+ | EUR Shares | EUR 1.1594 | +2.52% | +2.77% | +--------------+--------------+-------------+-------------+ | US$ Shares | US$ 1.6339 | +2.82% | +3.32% | +--------------+--------------+-------------+-------------+ These valuations, which have been prepared in good faith by the Company's administrator, are for information purposes only and are based on the unaudited estimated valuations supplied to the Company's investment adviser by the administrators or managers of the Company's underlying investments and such valuations may not be considered independent or may be subject to potential conflicts of interest. Both weekly manager estimates and monthly valuations may be produced as at valuation dates which do not co-incide with valuation dates for the Company, may be based on valuations provided as of a significantly earlier date, may differ materially from the actual value of the Company's portfolio and are unaudited or may be subject to little verification or other due diligence and may not comply with generally accepted accounting practices or other generally accepted valuation principles. The Company's investment adviser, investment manager and administrator may not have sufficient information to confirm or review the completeness or accuracy of information provided by those managers or administrators of the Company's investments. In addition, those entities may not provide estimates of the value of the underlying funds in which the Company invests on a regular or timely basis or at all with the result that the values of such investments may be estimated by the investment manager. In the case of 4 of the Company's 51 investments, where no such formal valuation has been received by today's date, an estimated valuation prepared by the Company's investment adviser or by the manager or administrator of the underlying funds has been used. Certain other risk factors which may be relevant to these valuations are set out in the Company's prospectus dated 10 March 2006. Monthly Portfolio Review Investment Adviser Portfolio Outlook Positive performance across all strategies led to an overall gain for the Portfolio. As the global economic recovery theme grew in popularity and spread across virtually all sectors, outstanding returns were recorded from the underlying managers in the Portfolio's Healthcare and Emerging Market strategies. The Portfolio remains highly flexible with the underlying managers able to extract alpha from directional and spread trades, while the significant long volatility exposure within the portfolio should serve it well should market conditions deteriorate significantly. Market Overview Asian Opportunities: +2.32%. Managers took advantage of the improved sentiment towards Asia and a weakening US Dollar to deliver positive returns. Performance was underpinned by strong gains from core positions in financial and consumer discretionary sectors, especially in Hong Kong and China. One manager saw strong price appreciation in some of its smaller cap names as the rally broadened to less liquid stocks. Those managers with a more balanced portfolio, as well as portfolios focusing more on South-East Asia and less on China and India, produced lower but nevertheless positive returns. The only fund to report a loss was a multi-strategy manager with long volatility exposure who was hurt by a significant contraction of implied equity volatility and Asian credit spreads. Healthcare Opportunities: +9.44%. The most significant position in the strategy began the month with net exposure of +100%, providing the manager with ample opportunity to capture the market moves and add alpha through security selection. Two of the fund's top holdings, a medical device company and a pharmaceutical company, appreciated +21% and +17% respectively. Special Situations: +3.75%. Positive returns for all managers were led by a manager who bounced back after last month's loss to post strong gains from gold exposure, with one of its holdings, Anglo Gold Ashanti, rising 35%. As credit markets experienced another strong month, the Portfolio's Distressed managers were both up. One manager made money across all sub-sectors, profiting from a reduction in short exposure and a subsequent increase in long exposure, with strong returns out of the auto sector, particularly Chrysler Finance. The Portfolio's other Distressed manager was slightly up, although it underperformed its peers due to a macro hedge and illiquid positions which failed to participate in the credit rally. Emerging Markets Macro: +5.46%. Managers profited from the continued appetite for risky assets. Long positions in credit and equities in developing countries drove profits for two managers, while another manager profited from positions in Brazilian and Mexican fixed income and currency markets, as well as a rally in their legacy positions. The Portfolio's managers have gradually increased risk during the month and are cautiously optimistic about the outlook for emerging market investing. Commodity Strategies: +3.49%. The majority of commodity sectors rallied during the course of the month. In Canada the S&P/TSX materials sector rose 21%, driving one manager's performance upwards through exposure to precious and base metal mining stocks. Elsewhere, diversified funds with a directional bias were up, with one manager benefiting from their bullish stance on energy. Base metals were broadly positive, with managers making money on long copper calendar spreads and long nickel option positions. While losses were limited, one manager was caught on the wrong side of the commodity rally, losing from bear spread positioning at the front ends of various commodity yield curves. Energy & Emissions: +2.26. A continued decline in the US Dollar and stronger energy prices, as Chinese demand and OPEC's apparent control of oil production, helped maintain recent investor buying trends. After months of underperformance, natural gas moved higher in tandem with the rest of the energy complex. One manager, who has been bearish front month natural gas for a few months, was negatively impacted. On the plus side, significant returns were derived from investments oil and gas exploration companies and European utility stocks, where long positions drove returns in an environment of share price strength. Environmental Strategies: +2.34%. The continued recovery in global equity markets provided a positive tailwind for the Portfolio's Environmental long/short equity managers. The Portfolio's Asian-focused clean technology fund held core positions in wind companies which rose sharply and contributed to the managers +19% return. The water sector posted gains, with strong performance in the Asian water space helping the Portfolio's water focused manager. Carbon markets staged a solid rally with CER futures up 10.5% and EUAs up 5.2%. While the spread narrowing did not have a negative impact on the carbon manager, the manager's short positioning did detract from performance. Short-Term Managed Futures: +3.37%. Bullish investor sentiment drove risk assets higher, proving favourable for the Portfolio's short term traders. Strong contribution came from one manager who took advantage of a sharp worldwide downward move in mid-May 2009 and the subsequent strong recovery in equities a week later. Another manager saw returns from a number of positions in currencies, soft commodities and metals. European Loan Opportunities: +4.49%. The leveraged loan market maintained rallies from earlier in the year and posted strong gains. The secondary market rally was not only limited to better performing credits or flow names but also extended to names that had previously been untouched. As a consequence, bids were registered from investors looking for value in performing, but more illiquid, names. +-------------------------+------------+----------+-----------+-------------+ | Strategy |Allocation | Number | Performance by | | | as of 1 |of Funds | Strategy | | | June | as of 1 | % | | | % | June | | +-------------------------+------------+----------+-------------------------+ | | | | May | YTD | +-------------------------+------------+----------+-----------+-------------+ | Asian Opportunities | 21 | 6 | 2.32 | 4.72 | +-------------------------+------------+----------+-----------+-------------+ | Healthcare | 4 | 3 | 9.44 | 3.37 | | Opportunities | | | | | +-------------------------+------------+----------+-----------+-------------+ | Special Situations | 14 | 5 | 3.75 | 4.58 | +-------------------------+------------+----------+-----------+-------------+ | Emerging Markets Macro | 4 | 3 | 5.46 | 14.69 | +-------------------------+------------+----------+-----------+-------------+ | Commodity Strategies | 8 | 10 | 3.49 | 6.46 | +-------------------------+------------+----------+-----------+-------------+ | Energy and Emissions | 19 | 12 | 2.26 | 6.28 | +-------------------------+------------+----------+-----------+-------------+ | Environmental | 7 | 7 | 2.34 | 8.02 | | Strategies | | | | | +-------------------------+------------+----------+-----------+-------------+ | Short-Term Managed | 15 | 4 | 3.37 | 3.84 | | Futures | | | | | +-------------------------+------------+----------+-----------+-------------+ | European Loan | 8 | 1 | 4.49 | 9.28 | | Opportunities EUR | | | | | +-------------------------+------------+----------+-----------+-------------+ | Total | 100 | 51 | | | +-------------------------+------------+----------+-----------+-------------+ Strategy returns are in US$ (except where annotated) and net of underlying manager fees only, and not inclusive of Dexion Alpha Strategies' fees and expenses. Voting Rights and Capital The Company's share capital consists of 69,555,941 GBP shares (excluding treasury shares) with voting rights, 15,898,020 EUR Shares (excluding treasury shares) and 1,362,223 US$ Shares (excluding treasury shares) with voting rights. All Shareholders have equal voting rights based on the number of Shares held. Accordingly, the total number of voting rights in the Company is 86,816,184 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FSA's Disclosure and Transparency Rules. Supplementary Information Click on, or paste the following link into your web browser, to view a full review of the Dexion Alpha Strategies Limited portfolio. http://www.rns-pdf.londonstockexchange.com/rns/8143U_-2009-6-30.pdf This information is provided by RNS The company news service from the London Stock Exchange END NAVEADKEDSPNEFE
1 Year Dexion Alpha Strategies Chart |
1 Month Dexion Alpha Strategies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions